Table 5.
Group | n | Short-term outcome (6 months) | |||
---|---|---|---|---|---|
A | B | C | D | ||
MPA-AUC <30.67 μg·h/ml | 13 | 4 | 8 | 1 | 0 |
MPA-AUC ≥30.67 μg·h/ml | 28 | 22 | 5 | 0 | 1 |
Total | 41 | 26 | 13 | 1 | 1 |
χ2=8.744, P=0.03.
Group | n | Short-term outcome (6 months) | |||
---|---|---|---|---|---|
A | B | C | D | ||
MPA-AUC <30.67 μg·h/ml | 13 | 4 | 8 | 1 | 0 |
MPA-AUC ≥30.67 μg·h/ml | 28 | 22 | 5 | 0 | 1 |
Total | 41 | 26 | 13 | 1 | 1 |
χ2=8.744, P=0.03.